Patents for A61K 49 - Preparations for testing in vivo (35,376)
05/2013
05/29/2013CN102151336B Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor
05/29/2013CN101951964B Imaging method
05/29/2013CN101878213B Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
05/29/2013CN101765562B Process for production of surface-coated inorganic particles
05/28/2013US8450462 Compound
05/28/2013US8449909 Abuse-deterrent drug formulations
05/28/2013US8449866 Cellular labeling for nuclear magnetic resonance techniques
05/28/2013US8449865 Drying process
05/28/2013CA2575601C Methods for producing compositions comprising hyperpolarized 13c-pyruvate
05/28/2013CA2476773C Monoclonal antibodies against extracellular loops of c5ar
05/28/2013CA2470597C Artificial bone mineral substitute material containing a ceramic and a water soluble non-ionic x-ray contrast agent
05/23/2013WO2013072717A1 Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
05/23/2013WO2013072526A1 Selective imaging of actin in live native cells
05/23/2013WO2013072071A1 Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
05/23/2013WO2013071413A1 Methods for the synthesis of 13c labeled iodotridecane and use as a reference standard
05/23/2013WO2013071412A1 Methods for the synthesis of 13c labeled plasmalogen
05/23/2013WO2013071411A1 Methods for the synthesis of 13c labeled dha and use as a reference standard
05/23/2013WO2013048022A3 Α-type zinc- phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an α-type zinc- phthalocyanine nanowire/phenothiazine, and method for preparing same
05/23/2013WO2013045650A3 Infusion imaging method
05/23/2013WO2013022499A3 Polymer coated metal particles and uses related thereto
05/23/2013US20130131354 Naphthocyanines for Use as Contrast Agents
05/23/2013US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/23/2013US20130129636 Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging
05/23/2013US20130129635 Polymerized shell lipid microbubbles and uses thereof
05/23/2013US20130129634 Intrinsically magnetic hydroxyapatite
05/23/2013US20130129633 Multimodal nanoparticles for non-invasive bio-imaging
05/23/2013US20130129632 Quantum dot materials, methods for making them, and uses thereof
05/23/2013US20130129631 Fluorescent Probe for Imaging Lymph Nodes
05/23/2013US20130129629 Modulation of bcl11a for treatment of hemoglobinopathies
05/23/2013US20130129619 Molecular Imaging of Cancer Cells In Vivo
05/23/2013US20130129618 Egcg stabilized gold nanoparticles and method for making same
05/23/2013US20130129616 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue
05/23/2013US20130129614 Microorganisms for imaging and/or treatment of tumors
05/22/2013EP2594568A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
05/22/2013EP2594290A1 Selective imaging of actin in live native cells
05/22/2013EP2593186A1 Nanoparticle-guided radiotherapy
05/22/2013EP2593143A1 X-ray imaging at low contrast agent concentrations and/or low dose radiation
05/22/2013EP2593086A1 Lipid bilayer carrier for drugs or imaging agents
05/22/2013CN103110965A Ferroferric oxide nanometer material as well as preparation method and application thereof
05/22/2013CN103110964A Dual-mode contrast medium with fluorescence and magnetic resonance imaging and preparation method thereof
05/22/2013CN103110963A Dual-mode synergistically-enhanced magnetic-resonance contrast agent and method for synthesizing same
05/22/2013CN103110962A Traditional Chinese medicine placebo, as well as preparation process and evaluation method thereof
05/22/2013CN103110961A Preparation method of high-definition endoscope mucus-removal defoaming composite preparation
05/22/2013CN101721718B Lipid microbubble and preparation method thereof
05/22/2013CN101678047B Remedy and diagnostic agent for mitochondrial dysfunction brain disease
05/21/2013US8447386 Marker or filler forming fluid
05/21/2013US8445660 Chimeric vaccines
05/21/2013US8445644 ErbB interface peptidomimetics and methods of use thereof
05/21/2013US8445431 Ligands having metal binding ability and targeting properties
05/21/2013US8445010 Abuse potential reduction in abusable substance dosage form
05/21/2013US8444983 Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
05/21/2013US8444977 Assay method for Alzheimer's disease
05/21/2013US8444957 Methods of screening for neoplastic disease states
05/21/2013CA2460092C A method of diagnosis and treatment and agents useful for same
05/21/2013CA2451109C Infection control system
05/17/2013CA2812432A1 Methods for the synthesis of 13c labeled dha and use as a reference standard
05/16/2013WO2013068896A1 Spectral imaging
05/16/2013WO2012136958A8 Optical imaging probes
05/16/2013US20130121929 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents
05/16/2013US20130121928 Method for Diagnostically Imaging Lesions in the Peripheral Nervous System
05/16/2013US20130121925 Optical determination of glucose utilizing boronic acid adducts
05/16/2013US20130121924 Fluorescence detection of poison oak oil
05/16/2013US20130121922 Methods for evaluating and selecting dermal filler compositions
05/16/2013US20130121920 Methods for evaluating dermal filler compositions
05/16/2013US20130121919 Histone acetyltransferase activators and uses thereof
05/16/2013US20130121916 Compositions for Colon Lavage and Methods of Making and Using Same
05/16/2013DE19941756B4 Verfahren zur Verwendung von oligomeren Nucleinsäure-Protein-Konjugaten als Reagenzien für immunologische Nachweisverfahren insbesondere die Immuno-PCR A method of using oligomeric nucleic acid-protein conjugates as reagents for immunological detection methods in particular, the Immuno-PCR
05/15/2013EP2591807A1 Process for preparing a pharmaceutical formulation of contrast agents
05/15/2013EP2591804A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
05/15/2013EP2590503A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof
05/15/2013CN103102479A Reduction sensitive fluorescent nano micelle with FRET (Fluorescence Resonance Energy Transfer) effect and preparation method thereof
05/15/2013CN103100093A Load small interfering RNA nanoscale lipid microbubble ultrasonic contrast agent and preparation method
05/15/2013CN103099781A Liposome, a pharmaceutical composition comprising the liposome, and a method of delivering active agents to a target site using the liposome
05/15/2013CN103099780A Preparation method of hydrogen-microbubble-containing aqueous solution, and product and application of method
05/15/2013CN103099604A An imaging method of tumor targeting based on enhancement effect of zinc ion signals
05/14/2013US8440628 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone
05/14/2013US8440623 Polymer stabilized neuropeptides
05/14/2013US8440622 Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)
05/14/2013US8440170 Orally disintegrating tablets with speckled appearance
05/14/2013US8440168 Image-guided therapy of myocardial disease: composition, manufacturing and applications
05/14/2013US8440167 Multimodal imaging of atherosclerotic plaque targeted to LOX-1
05/14/2013CA2642779C Superparamagnetic nanoparticles based on iron oxides with modified surface, method of their preparation and application
05/14/2013CA2563692C Compositions and methods for enhancing contrast in imaging
05/10/2013WO2013065002A1 Combination of a nanoparticle comprising a charged core made of phospholipid with a protein - use for the in vitro delivery of said protein
05/10/2013WO2013038271A4 Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
05/10/2013WO2012177701A3 Compositions, methods of synthesis and use of carbohydrate targeted agents
05/10/2013CA2854131A1 Use of an anti-.alpha.-synuclein antibody to diagnose an elevated level of .alpha.-synuclein in the brain
05/09/2013US20130116554 X-ray imaging at low contrast agent concentrations and/or low dose radiation
05/09/2013US20130115172 Magnetic nanophosphor having core/shell structure and the synthetic method thereof
05/09/2013US20130115171 Nav1.7-related assays
05/09/2013US20130115170 Gm1-like peptides and uses thereof
05/09/2013US20130115167 Peptides that home to atherosclerotic plaques and methods of use
05/08/2013EP2589391A2 Method for treating and diagnosing cancer by using cell-derived microvesicles
05/08/2013EP2589377A2 Microvesicles derived from cell protoplast, and use thereof
05/08/2013EP2589343A1 Metal mixes for use in epicutaneous patch test
05/08/2013EP2588145A1 Synthesis of high-performance iron oxide particle tracers for magnetic particle imaging (mpi)
05/08/2013EP2588144A2 Detecting targets using mass tags and mass spectrometry
05/08/2013EP2588078A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution
05/08/2013CN103096935A Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same
05/08/2013CN103096866A Kit and method for detecting porous dental hydroxy apatite
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 354